nucleic acid based gene therapy market, global nucleic acid based gene therapy market, nucleic acid based gene therapy market trends, nucleic acid based gene therapy market forecast, nucleic acid based gene therapy market analysis, nucleic acid-based therapeutics market, nucleic acid based gene therapy global market report 2021, nucleotide therapy market, gene therapy industry report, nucleic acid based gene therapy market report 2020

Nucleic Acid Based Gene Therapy Market 2022 - By Nucleic Acid Technology (Anti-Sense and Anti-Gene Oligonucleotides, siRNA and RNA Interference, Gene Transfer Therapy, Ribozymes, Aptamers), By Application (Oncology, Muscular Dystrophy/ Muscular Disorders, Rare Diseases), By End User (Hospitals And Clinics, Academic And Research Institutes), And By Region, Opportunities And Strategies – Global Forecast To 2030

Name: nucleic acid based gene therapy market, global nucleic acid based gene therapy market, nucleic acid based gene therapy market trends, nucleic acid based gene therapy market forecast, nucleic acid based gene therapy market analysis, nucleic acid-based therapeutics market, nucleic acid based gene therapy global market report 2021, nucleotide therapy market, gene therapy industry report, nucleic acid based gene therapy market report 2020
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

nucleic acid based gene therapy market, global nucleic acid based gene therapy market, nucleic acid based gene therapy market trends, nucleic acid based gene therapy market forecast, nucleic acid based gene therapy market analysis, nucleic acid-based therapeutics market, nucleic acid based gene therapy global market report 2021, nucleotide therapy market, gene therapy industry report, nucleic acid based gene therapy market report 2020

Starting Price : $5000.00 $3500.00 | Pages : 222 | Published : January 2022 | | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

Need assistance or more information before the purchase?

Enquire Before Buying

Proud Members Of

Nucleic Acid Based Gene Therapy Market Definition

The nucleic acid-based gene therapy market consists of sales of nucleic acid-based gene therapy products and services. Gene therapy is used for correcting defective genes that are responsible for disease development. Nucleic acid therapies are highly specific and long-lasting compared to the conventional therapies which are generally transient and have low specificity. Nucleic acid-based therapy either uses unmodified DNA or RNA or closely related compounds. Nucleic acid-based therapeutics are used to treat genetic disorders and diseases for which there is no permanent cure such as anemia, sickle cell, cystic fibrosis, diabetes, and thalassemia.

Gene therapy is a technique, which modifies genes to treat or prevent diseases. Genes are the basic physical and functional unit of heredity, received from one’s parents. Genes act as a code for the creation of all proteins in a living organism. Gene therapy seeks to manipulate a patient’s cells to alter the biological property of cells for the treatment of an inherited or acquired disease. It works by several mechanisms, including replacing a disease-causing gene with a healthy copy of the gene, inactivating an ill-functioning disease-causing gene, or introducing a modified gene into the body to treat diseases.

Book your 30 minutes free consultation with our research experts

Nucleic Acid Based Gene Therapy Market Size

The global nucleic acid-based gene therapy market grew from $1,391.9 million in 2015 to $4,726.8 million in 2020 at a compound annual growth rate (CAGR) of 27.7%. The nucleic acid-based gene therapy market is expected to grow from $4,726.8 million in 2020 to $7,282.9 million in 2025 at a rate of 9.0%. The nucleic acid-based gene therapy market is then expected to grow at a CAGR of 15.4% from 2025 and reach $14,909.6 million in 2030.

Growth in the historic period in the nucleic acid-based gene therapy market resulted from technological advances in synthetic biology, advances in combinatorial chemistry and bioinformatics, increased healthcare expenditure, rising pharmaceutical R&D expenditure, and rise in public-private partnerships. The nucleic acid-based gene therapy market was restrained by off-target specificity, challenges in nucleotide delivery to cells, instability of the nucleotides, inadequate reimbursements, challenges due to regulatory changes, low healthcare access, and limited number of treatment centers.

Going forward rise in healthcare expenditure, increasing prevalence of cancer and chronic diseases, rising geriatric population, rising geriatric population, increasing research and development spending and rising focus on gene therapy will drive the growth in the nucleic acid-based gene therapy market. Factors that could hinder the growth of the nucleic acid-based gene therapy market in the future include high costs of therapy, stringent regulations, reimbursement challenges, and coronavirus pandemic.

Nucleic Acid Based Gene Therapy Market Drivers

The key drivers of the nucleic acid based gene therapy market include:

Rise In Healthcare Expenditure

Increasing healthcare expenditure is predicted to upsurge the demand for the nucleic acid-based gene therapy market. The growth in healthcare expenditure is aiding governments and organizations to spend more on prescription drugs, hospitals, and physical & clinical services, thereby driving the nucleic acid-based gene therapy market. According to the National Health Expenditure Projections 2018-2027, national healthcare expenditure is expected to reach nearly $6.0 trillion by 2027 in the USA, growing at an average rate of 5.5% annually from 2018 to 2027. Furthermore, prescription drug spending is projected to grow by 6.1% annually during 2020-2027. Also, in terms of annual spending on approved gene therapies, it has reached $5.15 billion in 2020, and will increase to $25.3 billion by 2026. Thus, the rise in healthcare spending is to increase the market for nucleic acid-based gene therapy in the near future.

Nucleic Acid Based Gene Therapy Market Restraints

The key restraints on the nucleic acid based gene therapy market include:

High Costs Of Therapy

High costs associated with nucleic acid-based gene therapy is a major issue faced by citizens of many countries. The pressure to contain costs and demonstrate value is widespread. Political uncertainty and persistent economic stress in numerous countries are calling into question the sustainability of public health care funding. In less wealthy countries, the lack of cost-effective therapies for cancer has influenced the health conditions of the population and has led to a low average life expectancy. Thus, the high cost of therapy is restraining the growth of the nucleic acid-based gene therapy market.

Nucleic Acid Based Gene Therapy Market Trends

Major trends influencing the nucleic acid based gene therapy market include:

Global Research Initiatives And Funding

Pharmaceutical companies and federal governments are increasingly working together in partnerships and collaborations to provide funding and implement incentive programs for the research and development (R&D) of gene therapy. These partnerships provide financial and technical assistance across different clinical development phases to pharmaceutical companies. For instance, in 2020, The University of Bristol has secured a £45 million (US$ 61 million) to spin-out Purespring Therapeutics from Syncona Ltd for its gene therapy technology for chronic kidney disease. In October 2019, the National Institutes of Health (NIH) and the Bill & Melinda Gates Foundation pledge to invest $200 million over the next four years to speed the development of affordable gene therapies for human immunodeficiency virus (HIV) and sickle cell disease (SCD) on a global scale.

Integration Of Advanced Technologies In Gene Therapy

Major players operating in the nucleic acid-based gene therapy market are continuously collaborating or partnering with technology companies to integrate advanced technologies for the improvement of gene therapy. Advanced technologies such as artificial intelligence (AI) and big data are used for personalizing and manufacturing improved gene therapy. Machine Learning enables accelerated analysis of the sequenced data and enables effective prediction of the genetic alterations associated with a disease. This helps in reducing the time and effort required in the process of developing precision medicine. For instance, in September 2021, Mila, a Canada-based artificial intelligence research institute has partnered with Deep Genomics, a therapeutic artificial intelligence treatments provider. The partnership is to join the Mila community and take advantage of the recruitment services offered by the research institute. In July 2021, I-Mab Biopharma Co. Ltd., China-based biotechnology company collaborated with Immorna Biotechnology Co. Ltd., a mRNA biotech company and Neox Biotech Co. Ltd., an Artificial Intelligence-enabled research & development company for gaining access to transformative technologies to innovate and develop oncology therapeutics.

Opportunities And Recommendations In The Nucleic Acid Based Gene Therapy Market

Opportunities –The top opportunities in the nucleic acid-based gene therapy market segmented by technology will arise in the anti-sense and anti-gene oligonucleotides segment, which will gain $1,290.7 million of global annual sales by 2025. The top opportunities in the nucleic-acid based gene therapy market segmented by application will arise in the muscular dystrophy/muscular disorders segment, which will gain $1,000.2 million of global annual sales by 2025. The top opportunities in the nucleic-acid based gene therapy market segmented by application will arise in the hospitals and clinics segment, which will gain $2,133.7 million of global annual sales by 2025. The nucleic acid-based gene therapy market size will gain the most in the USA at $915.0 million .

Recommendations-To take advantage of the opportunities, The Business Research Company recommends the nucleic acid-based gene therapy companies to focus on partnerships and acquisitions, focus on gene editing, expanding in emerging markets, scale up through collaborations, offer competitive pricing, participate in gene therapy seminars and conferences and to focus on collaborating with hospitals.

Nucleic Acid Based Gene Therapy Market Segmentation

Nucleic acid based gene therapy market is segmented by nucleic acid technology into:
By Nucleic Acid Technology –
The nucleic acid based gene therapy market is segmented by nucleic acid technology into

a) Anti-Sense and Anti-Gene Oligonucleotides
b) siRNA and RNA Interference
c) Gene Transfer Therapy
d) Ribozymes
e) Aptamers
f) Others

The anti-sense and anti-gene oligonucleotides market was the largest segment of the nucleic acid-based gene therapy market segmented by technology, accounting for 92.90% of the total in 2020. Going forward, the others segment is expected to be the fastest growing segment in the nucleic acid-based gene therapy market segmented by technology, at a CAGR of 59.9% during 2020-2025.
By Application –
The nucleic acid based gene therapy market is segmented by application into

a) Oncology
b) Muscular Dystrophy/ Muscular Disorders
c) Rare Diseases
d) Others

The muscular dystrophy/muscular disorders market was the largest segment of the nucleic acid-based gene therapy market segmented by application, accounting for 61.4% of the total in 2020. Going forward, the oncology segment is expected to be the fastest growing segment in the nucleic-acid based gene therapy market segmented by application, at a CAGR of 18.1% during 2020-2025.
By End User –
The nucleic acid based gene therapy market is segmented by end user into

a) Hospitals And Clinics
b) Academic And Research Institutes

The hospitals and clinics market was the largest segment of the nucleic acid-based gene therapy market segmented by end-user, accounting for 85.0% of the total in 2020. Going forward, the academic and research institutes segment is expected to be the fastest growing segment in the nucleic-acid based gene therapy market segmented by end-user, at a CAGR of 9.8% during 2020-2025.
By Geography -
The nucleic acid based gene therapy market is segmented by geography into

• USA

• UK
• Germany
• France

China
India
Australia
Indonesia
Japan
South Korea

• Russia

• Brazil

North America was the largest region in the global nucleic acid-based gene therapy market, accounting for 46.2% of the total in 2020. It was followed by the Western Europe, Asia Pacific and then the other regions. Going forward, the fastest-growing regions in the nucleic acid-based gene therapy market will be the Middle East and Eastern Europe where growth will be at CAGRs of 33.7% and 26.0% respectively. These will be followed by South America and Asia Pacific, where the markets are expected to register CAGRs of 21.0% and 20.4% respectively.

Nucleic Acid Based Gene Therapy Competitive Landscape

Major Competitors Are:

Copernicus Therapeutics

Moderna Inc.

Wave Life Sciences

Protagonist Therapeutics

Transgene

Other Competitors Include:

uniQure NV

Sarepta Therapeutics Inc.

Oxford Biomedica

Benitec Biopharma

PYC Therapeutics Limited

Imugene Ltd

Benitec Biopharma Ltd

EdiGene, Inc.

GenScript

Biomics Biotechnologies (Nantong) Co., Ltd.

Auris Medical Holding Ltd

Akcea Therapeutics

Arctoris Limited

BioNTech SE

Freeline Therapeutics

Celyad Oncology

Cellectis

Celgene Corporation

Johnson & Johnson

F. Hoffmann-La Roche Ltd

Eli Lilly and Company

Pfizer

AstraZeneca

Bayer AG

Voyager Therapeutics Inc.

Roche Holding AG

Gilead Sciences, Inc.

Amgen Brasil

Biogen Brazil

Novartis

Middle East Gene Therapy Company

DEVA

Biotchpharma

Gene Vector Technologies

BrainStorm Cell Therapeutics

Pluristem

Merck

Sanofi

Adcock Ingram

1. Nucleic Acid Based Gene Therapy Market Executive Summary

2. Table of Contents

3. List of Figures

4. List of Tables

5. Report Structure

6. Introduction

6.1. Segmentation By Geography

6.2. Segmentation By Technology

6.3. Segmentation By Application

6.4. Segmentation By End-User

7. Nucleic Acid Based Gene Therapy Market Characteristics

7.1. Market Definition

7.2. Segmentation By Nucleic Acid Technology

7.2.1. Anti-Sense and Anti-Gene Oligonucleotides

7.2.2. siRNA and RNA Interference

7.2.3. Gene Transfer Therapy

7.2.4. Ribozymes

7.2.5. Aptamers

7.2.6. Others

7.3. Segmentation By Application

7.3.1. Oncology

7.3.2. Muscular Dystrophy/ Muscular Disorders

7.3.3. Rare Diseases

7.3.4. Others

7.4. Segmentation By End-User

7.4.1. Hospitals And Clinics

7.4.2. Academic And Research Institutes

8. Nucleic Acid Based Gene Therapy Market Trends And Strategies

8.1. Global Research Initiatives And Funding

8.2. Integration Of Advanced Technologies In Gene Therapy

8.3. Increasing Partnerships And Acquisitions For Promoting Gene Therapy

8.4. Increasing Number Of Pipeline Studies And Drug Development

8.5. Growing Investments and Manufacturing Facility Expansion

8.6. Rising Focus On Gene Editing

9. Impact Of COVID-19 On The Nucleic Acid Based Gene Therapy Market

9.1. Introduction

9.2. Supply Chain Disruptions

9.3. Impact On Clinical Trials

9.4. Impact on Manufacturers and Activities

9.5. Conclusion

10. Global Nucleic Acid Based Gene Therapy Market Size And Growth

10.1. Market Size

10.2. Historic Market Growth, 2015 – 2020, Value ($ Million)

10.2.1. Drivers Of The Market 2015 – 2020

10.2.2. Restraints On The Market 2015 – 2020

10.3. Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

10.3.1. Drivers Of The Market 2020 – 2025

10.3.2. Restraints On The Market 2020 – 2025

11. Global Nucleic Acid Based Gene Therapy Market Segmentation

11.1. Global Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

11.2. Global Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

11.3. Global Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

12. Nucleic Acid Based Gene Therapy Market, Regional And Country Analysis

12.1. Global Nucleic Acid Based Gene Therapy Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

12.2. Global Nucleic Acid Based Gene Therapy Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

13. Asia-Pacific Nucleic Acid Based Gene Therapy Market

13.1. Asia-Pacific Nucleic Acid Based Gene Therapy Market Overview

13.1.1. Region Information

13.1.2. Market Information

13.1.3. Background Information

13.1.4. Government Initiatives

13.1.5. Regulations

13.1.6. Regulatory Bodies

13.1.7. Major Associations

13.1.8. Taxes Levied

13.1.9. Corporate Tax Structure

13.1.10. Investments

13.1.11. Major Companies

13.2. Asia-Pacific Nucleic Acid Based Gene Therapy Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

13.3. Asia-Pacific Nucleic Acid Based Gene Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

13.4. Asia-Pacific Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

13.5. Asia-Pacific Nucleic Acid Based Gene Therapy Market: Country Analysis

13.6. China Nucleic Acid Based Gene Therapy Market

13.7. China Nucleic Acid Based Gene Therapy Market Overview

13.7.1. Country Information

13.7.2. Market Information

13.7.3. Background Information

13.7.4. Government Initiatives

13.7.5. Regulations

13.7.6. Regulatory Bodies

13.7.7. Major Associations

13.7.8. Taxes Levied

13.7.9. Corporate Tax Structure

13.7.10. Investments

13.7.11. Major Companies

13.8. China Nucleic Acid Based Gene Therapy Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

13.9. China Nucleic Acid Based Gene Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

13.10. China Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

13.11. India Nucleic Acid Based Gene Therapy Market

13.12. India Nucleic Acid Based Gene Therapy Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

13.13. India Nucleic Acid Based Gene Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

13.14. India Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

13.15. Japan Nucleic Acid Based Gene Therapy Market

13.16. Japan Nucleic Acid Based Gene Therapy Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

13.17. Japan Nucleic Acid Based Gene Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

13.18. Japan Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

13.19. Australia Nucleic Acid Based Gene Therapy Market

13.20. Australia Nucleic Acid Based Gene Therapy Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

13.21. Australia Nucleic Acid Based Gene Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

13.22. Australia Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

13.23. Indonesia Nucleic Acid Based Gene Therapy Market

13.24. Indonesia Nucleic Acid Based Gene Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

13.25. Indonesia Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

13.26. South Korea Nucleic Acid Based Gene Therapy Market

13.27. South Korea Nucleic Acid Based Gene Therapy Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

13.28. South Korea Nucleic Acid Based Gene Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

13.29. South Korea Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

14. Western Europe Nucleic Acid Based Gene Therapy Market

14.1. Western Europe Nucleic Acid Based Gene Therapy Market Overview

14.1.1. Region Information

14.1.2. Market Information

14.1.3. Background Information

14.1.4. Government Initiatives

14.1.5. Regulations

14.1.6. Regulatory Bodies

14.1.7. Major Associations

14.1.8. Taxes Levied

14.1.9. Corporate Tax Structure

14.1.10. Investments

14.1.11. Major Companies

14.2. Western Europe Nucleic Acid Based Gene Therapy Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

14.3. Western Europe Nucleic Acid Based Gene Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

14.4. Western Europe Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

14.5. Western Europe Nucleic Acid Based Gene Therapy Market: Country Analysis

14.6. UK Nucleic Acid Based Gene Therapy Market

14.7. UK Nucleic Acid Based Gene Therapy Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

14.8. UK Nucleic Acid Based Gene Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

14.9. UK Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

14.10. Germany Nucleic Acid Based Gene Therapy Market

14.11. Germany Nucleic Acid Based Gene Therapy Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

14.12. Germany Nucleic Acid Based Gene Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

14.13. Germany Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

14.14. France Nucleic Acid Based Gene Therapy Market

14.15. France Nucleic Acid Based Gene Therapy Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

14.16. France Nucleic Acid Based Gene Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

14.17. France Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

15. Eastern Europe Nucleic Acid Based Gene Therapy Market

15.1. Eastern Europe Nucleic Acid Based Gene Therapy Market Overview

15.1.1. Region Information

15.1.2. Market Information

15.1.3. Background Information

15.1.4. Government Initiatives

15.1.5. Regulations

15.1.6. Regulatory Bodies

15.1.7. Major Associations

15.1.8. Taxes Levied

15.1.9. Corporate Tax Structure

15.1.10. Investments

15.1.11. Major Companies

15.2. Eastern Europe Nucleic Acid Based Gene Therapy Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

15.3. Eastern Europe Nucleic Acid Based Gene Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

15.4. Eastern Europe Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

15.5. Eastern Europe Nucleic Acid Based Gene Therapy Market: Country Analysis

15.6. Russia Nucleic Acid Based Gene Therapy Market

15.7. Russia Nucleic Acid Based Gene Therapy Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

15.8. Russia Nucleic Acid Based Gene Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

15.9. Russia Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

16. North America Nucleic Acid Based Gene Therapy Market

16.1. North America Nucleic Acid Based Gene Therapy Market Overview

16.1.1. Region Information

16.1.2. Market Information

16.1.3. Background information

16.1.4. Government Initiatives

16.1.5. Regulations

16.1.6. Regulatory Bodies

16.1.7. Major Associations

16.1.8. Taxes levied

16.1.9. Corporate Tax Structure

16.1.10. Investments

16.1.11. Major Companies

16.2. North America Nucleic Acid Based Gene Therapy Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

16.3. North America Nucleic Acid Based Gene Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

16.4. North America Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

16.5. North America Nucleic Acid Based Gene Therapy Market: Country Analysis

16.6. USA Nucleic Acid Based Gene Therapy Market

16.7. USA Nucleic Acid Based Gene Therapy Market Overview

16.7.1. Country Information

16.7.2. Market Information

16.7.3. Background information

16.7.4. Government Initiatives

16.7.5. Regulations

16.7.6. Regulatory Bodies

16.7.7. Major Associations

16.7.8. Taxes levied

16.7.9. Corporate Tax Structure

16.7.10. Investments

16.7.11. Major Companies

16.8. USA Nucleic Acid Based Gene Therapy Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

16.9. USA Nucleic Acid Based Gene Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

16.10. USA Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

17. South America Nucleic Acid Based Gene Therapy Market

17.1. South America Nucleic Acid Based Gene Therapy Market Overview

17.1.1. Region Information

17.1.2. Market Information

17.1.3. Background Information

17.1.4. Government Initiatives

17.1.5. Regulations

17.1.6. Regulatory Bodies

17.1.7. Major Associations

17.1.8. Taxes Levied

17.1.9. Corporate Tax Structure

17.1.10. Investments

17.1.11. Major Companies

17.2. South America Nucleic Acid Based Gene Therapy Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

17.3. South America Nucleic Acid Based Gene Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

17.4. South America Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

17.5. South America Nucleic Acid Based Gene Therapy Market: Country Analysis

17.6. Brazil Nucleic Acid Based Gene Therapy Market

17.7. Brazil Nucleic Acid Based Gene Therapy Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

17.8. Brazil Nucleic Acid Based Gene Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

17.9. Brazil Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

18. Middle East Nucleic Acid Based Gene Therapy Market

18.1. Middle East Nucleic Acid Based Gene Therapy Market Overview

18.1.1. Region Information

18.1.2. Market Information

18.1.3. Background information

18.1.4. Government Initiatives

18.1.5. Regulations

18.1.6. Regulatory Bodies

18.1.7. Major Associations

18.1.8. Taxes levied

18.1.9. Corporate Tax Structure

18.1.10. Investments

18.1.11. Major Companies

18.2. Middle East Nucleic Acid Based Gene Therapy Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

18.3.Middle East Nucleic Acid Based Gene Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

18.4. Middle East Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

19. Africa Nucleic Acid Based Gene Therapy Market

19.1. Africa Nucleic Acid Based Gene Therapy Market Overview

19.1.1. Region Information

19.1.2. Market Information

19.1.3. Background information

19.1.4. Government Initiatives

19.1.5. Regulations

19.1.6. Regulatory Bodies

19.1.7. Major Associations

19.1.8. Taxes levied

19.1.9. Corporate Tax Structure

19.1.10. Investments

19.1.11. Major Companies

19.2. Africa Nucleic Acid Based Gene Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

19.3. Africa Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

20. Global Nucleic Acid Based Gene Therapy Market Competitive Landscape

20.1. Company Profiles

20.2. Copernicus Therapeutics

20.2.1. Company Overview

20.2.2. Products And Services

20.2.3. Business Strategy

20.2.4. Financial Overview

20.3. Moderna Inc.

20.3.1. Company Overview

20.3.2. Products And Services

20.3.3. Business Strategy

20.3.4. Financial Overview

20.4. Wave Life Sciences

20.4.1. Company Overview

20.4.2. Products And Services

20.4.3. Business Strategy

20.4.4. Financial Overview

20.5. Protagonist Therapeutics

20.5.1. Company Overview

20.5.2. Products And Services

20.5.3. Financial Overview

20.6. Transgene

20.6.1. Company Overview

20.6.2. Products And Services

20.6.3. Business Strategy

20.6.4. Financial Overview

21. Nucleic Acid-based gene Therapy Market Pipeline Analysis

22. Key Mergers And Acquisitions In The Nucleic Acid-based gene Therapy Market

22.1. Sanofi Acquired Tidal Therapeutics

22.2. NeuBase Therapeutics Acquired Vera Therapeutics

22.3. Astellas Acquired Audentes Therapeutics

22.4. Roche Acquired Spark Therapeutics Incorporated

22.5. Vertex Acquired Semma Therapeutics

22.6. Pfizer Acquired Vivet Therapeutics

22.7. Vectalys And FlashCell Merge To Create Flash Therapeutics

22.8. Novartis Acquired AveXis

22.9. CSL Behring Acquired Calimmune

23. Global Nucleic Acid Based Gene Therapy Market Opportunities And Strategies

23.1. Global Nucleic Acid Based Gene Therapy Market In 2025 – Countries Offering Most New Opportunities

23.2. Global Nucleic Acid Based Gene Therapy Market In 2025 – Segments Offering Most New Opportunities

23.3. Global Nucleic Acid Based Gene Therapy Market In 2025 – Growth Strategies

23.3.1. Market Trend Based Strategies

23.3.2. Competitor Strategies

24. Global Nucleic Acid Based Gene Therapy Market, Conclusions And Recommendations

24.1. Conclusions

24.2. Recommendations

24.2.1. Product

24.2.2. Place

24.2.3. Price

24.2.4. Promotion

24.2.5. People

25. Appendix

25.1. Market Data Sources

25.2. Research Methodology

25.3. Currencies

25.4. Research Inquiries

25.5. The Business Research Company

25.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Nucleic Acid Based Gene Therapy Market, Historic, 2015 – 2020, $ Million

Table 2: Global Nucleic Acid Based Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 3: Global Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 4: Global Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 5: Global Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 6: Global Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 7: Global Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 8: Global Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 9: Global Nucleic Acid Based Gene Therapy Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %

Table 10: Global Nucleic Acid Based Gene Therapy Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 11: Global Nucleic Acid Based Gene Therapy Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %

Table 12: Global Nucleic Acid Based Gene Therapy Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 13: Asia-Pacific Healthcare Expenditure, By Country, 2015-2020, $ Billion

Table 14: Asia Pacific GDP Per Capita, 2015-2020, $

Table 15: Asia-Pacific, Population By Age Group, By Country, 2015-2025, Thousands

Table 16: Asia Pacific Biologics Market, 2015-2025, $ Billion

Table 17: Asia-Pacific Nucleic Acid Based Gene Therapy Market, Historic, 2015 – 2020, $ Million

Table 18: Asia-Pacific Nucleic Acid Based Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 19: Asia-Pacific Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 20: Asia-Pacific Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 21: China Healthcare Expenditure, 2015-2019, $ Billion

Table 22: China GDP Per Capita, 2015-2020, $

Table 23: China, Population By Age Group, 2015-2025, Thousands

Table 24: Asia Pacific Biologics Market, 2015-2025, $ Billion

Table 25: China Nucleic Acid Based Gene Therapy Market, Historic, 2015 – 2020, $ Million

Table 26: China Nucleic Acid Based Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 27: China Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 28: China Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 29: India Nucleic Acid Based Gene Therapy Market, Historic, 2015 – 2020, $ Million

Table 30: India Nucleic Acid Based Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 31: India Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 32: India Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 33: Japan Nucleic Acid Based Gene Therapy Market, Historic, 2015 – 2020, $ Million

Table 34: Japan Nucleic Acid Based Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 35: Japan Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 36: Japan Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 37: Australia Nucleic Acid Based Gene Therapy Market, Historic, 2015 – 2020, $ Million

Table 38: Australia Nucleic Acid Based Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 39: Australia Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 40: Australia Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 41: Indonesia Nucleic Acid Based Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 42: Indonesia Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 43: Indonesia Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 44: South Korea Nucleic Acid Based Gene Therapy Market, Historic, 2015 – 2020, $ Million

Table 45: South Korea Nucleic Acid Based Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 46: South Korea Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 47: South Korea Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 48: Western Europe Healthcare Expenditure, By Country, 2015-2019, $ Billion

Table 49: Western Europe GDP Per Capita, 2015-2020, $

Table 50: Western Europe, Population By Age Group, By Country, 2015-2025, Thousands

Table 51: Western Europe Biologics Market, 2015-2025, $ Billion

Table 52: Western Europe Nucleic Acid Based Gene Therapy Market, Historic, 2015 – 2020, $ Million

Table 53: Western Europe Nucleic Acid Based Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 54: Western Europe Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 55: Western Europe Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 56: UK Nucleic Acid Based Gene Therapy Market, Historic, 2015 – 2020, $ Million

Table 57: UK Nucleic Acid Based Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 58: UK Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 59: UK Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 60: Germany Nucleic Acid Based Gene Therapy Market, Historic, 2015 – 2020, $ Million

Table 61: Germany Nucleic Acid Based Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 62: Germany Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 63: Germany Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 64: France Nucleic Acid Based Gene Therapy Market, Historic, 2015 – 2020, $ Million

Table 65: France Nucleic Acid Based Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 66: France Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 67: France Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 68: Eastern Europe Healthcare Expenditure, By Country, 2015-2019, $ Billion

Table 69: Eastern Europe GDP Per Capita, 2015-2020, $

Table 70: Eastern Europe, Population By Age Group, By Country, 2015-2025, Thousands

Table 71: Eastern Europe Biologics Market, 2015-2025, $ Billion

Table 72: Eastern Europe Nucleic Acid Based Gene Therapy Market, Historic, 2015 – 2020, $ Million

Table 73: Eastern Europe Nucleic Acid Based Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 74: Eastern Europe Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 75: Eastern Europe Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 76: Russia Nucleic Acid Based Gene Therapy Market, Historic, 2015 – 2020, $ Million

Table 77: Russia Nucleic Acid Based Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 78: Russia Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 79: Russia Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 80: North America Healthcare Expenditure, By Country, 2015-2019, $ Billion

Table 81: North America GDP Per Capita, 2015-2020, $

Table 82: North America, Population By Age Group, By Country, 2015-2025, Thousands

Table 83: North America Biologics Market, 2015-2025, $ Billion

Table 84: North America Nucleic Acid Based Gene Therapy Market, Historic, 2015 – 2020, $ Million

Table 85: North America Nucleic Acid Based Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 86: North America Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 87: North America Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 88: USA Healthcare Expenditure, 2015-2019, $ Billion

Table 89: USA GDP Per Capita, 2015-2020, $

Table 90: USA, Population By Age Group, 2015-2025, Thousands

Table 91: North America Biologics Market, 2015-2025, $ Billion

Table 92: USA Nucleic Acid Based Gene Therapy Market, Historic, 2015 – 2020, $ Million

Table 93: USA Nucleic Acid Based Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 94: USA Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 95: USA Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 96: South America Healthcare Expenditure, By Country, 2015-2019, $ Billion

Table 97: South America GDP Per Capita, 2015-2020, $

Table 98: South America, Population By Age Group, By Country, 2015-2025, Thousands

Table 99: South America Biologics Market, 2015-2025, $ Billion

Table 100: South America Nucleic Acid Based Gene Therapy Market, Historic, 2015 – 2020, $ Million

Table 101: South America Nucleic Acid Based Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 102: South America Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 103: South America Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 104: Brazil Nucleic Acid Based Gene Therapy Market, Historic, 2015 – 2020, $ Million

Table 105: Brazil Nucleic Acid Based Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 106: Brazil Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 107: Brazil Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 108: Middle East Healthcare Expenditure, By Country, 2015-2019, $ Billion

Table 109: Middle East GDP Per Capita, 2015-2020, $

Table 110: Middle East, Population By Age Group, By Country, 2015-2025, Thousands

Table 111: Middle East Biologics Market, 2015-2025, $ Billion

Table 112: Middle East Nucleic Acid Based Gene Therapy Market, Historic, 2015 – 2020, $ Million

Table 113: Middle East Nucleic Acid Based Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 114: Middle East Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 115: Middle East Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 116: Africa Healthcare Expenditure, By Country, 2015-2019, $ Billion

Table 117: Africa GDP Per Capita, 2015-2020, $

Table 118: Africa, Population By Age Group, By Country, 2015-2025, Thousands

Table 119: Middle East Biologics Market, 2015-2025, $ Billion

Table 120: Africa Nucleic Acid Based Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 121: Africa Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 122: Africa Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 123: Global Nucleic Acid Based Gene Therapy Market, Key Competitor Estimated Market Shares, 2020, Percentage (%)

Table 124: Moderna Inc. – Financial Performance, 2016 - 2020, $ Billion

Table 125: Wave Life Sciences – Financial Performance, 2016 - 2020, $ Million

Table 126: Protagonist Therapeutics – Financial Overview, 2017 - 2020, $ Million

Table 127: Global Nucleic Acid-based gene Therapy Market, Pipeline Analysis

Table 128: Global Nucleic Acid Based Gene Therapy Market Size Gain ($ Million), 2020 – 2025, By Country

Table 129: Global Nucleic Acid Based Gene Therapy Market Size Gain ($ Million), Segmentation By Technology, 2020 – 2025

Table 130: Global Nucleic Acid Based Gene Therapy Market Size Gain ($ Million), Segmentation By Application, 2020 – 2025

Table 131: Global Nucleic Acid Based Gene Therapy Market Size Gain ($ Million), Segmentation By Technology, 2020 – 2025

Table 132: Nucleic Acid Based Gene Therapy - Market Data Sources

List Of Figures

Figure 1: Global Nucleic Acid-based gene Therapy Market Segmentation By Technology

Figure 2: Global Nucleic Acid-based gene Therapy Market Segmentation By Application

Figure 3: Global Nucleic Acid-based gene Therapy Market Segmentation By End-User

Figure 4: Global Nucleic Acid Based Gene Therapy Market, Historic, 2015 – 2020, $ Million

Figure 5: Global Nucleic Acid Based Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 6: Global Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 7: Global Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 8: Global Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 9: Global Nucleic Acid Based Gene Therapy Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 10: Global Nucleic Acid Based Gene Therapy Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 11: Asia-Pacific Nucleic Acid Based Gene Therapy Market, Historic, 2015 – 2020, $ Million

Figure 12: Asia-Pacific Nucleic Acid Based Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 13: Asia-Pacific Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 14: China Nucleic Acid Based Gene Therapy Market, Historic, 2015 – 2020, $ Million

Figure 15: China Nucleic Acid Based Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 16: China Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 17: India Nucleic Acid Based Gene Therapy Market, Historic, 2015 – 2020, $ Million

Figure 18: India Nucleic Acid Based Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 19: India Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 20: Japan Nucleic Acid Based Gene Therapy Market, Historic, 2015 – 2020, $ Million

Figure 21: Japan Nucleic Acid Based Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 22: Japan Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 23: Australia Nucleic Acid Based Gene Therapy Market, Historic, 2015 – 2020, $ Million

Figure 24: Australia Nucleic Acid Based Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 25: Australia Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 26: Indonesia Nucleic Acid Based Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 27: Indonesia Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 28: South Korea Nucleic Acid Based Gene Therapy Market, Historic, 2015 – 2020, $ Million

Figure 29: South Korea Nucleic Acid Based Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 30: South Korea Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 31: Western Europe Nucleic Acid Based Gene Therapy Market, Historic, 2015 – 2020, $ Million

Figure 32: Western Europe Nucleic Acid Based Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 33: Western Europe Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 34: UK Nucleic Acid Based Gene Therapy Market, Historic, 2015 – 2020, $ Million

Figure 35: UK Nucleic Acid Based Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 36: UK Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 37: Germany Nucleic Acid Based Gene Therapy Market, Historic, 2015 – 2020, $ Million

Figure 38: Germany Nucleic Acid Based Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 39: Germany Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 40: France Nucleic Acid Based Gene Therapy Market, Historic, 2015 – 2020, $ Million

Figure 41: France Nucleic Acid Based Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 42: France Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 43: Eastern Europe Nucleic Acid Based Gene Therapy Market, Historic, 2015 – 2020, $ Million

Figure 44: Eastern Europe Nucleic Acid Based Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 45: Eastern Europe Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 46: Russia Nucleic Acid Based Gene Therapy Market, Historic, 2015 – 2020, $ Million

Figure 47: Russia Nucleic Acid Based Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 48: Russia Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 49: North America Nucleic Acid Based Gene Therapy Market, Historic, 2015 – 2020, $ Million

Figure 50: North America Nucleic Acid Based Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 51: North America Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 52: USA Nucleic Acid Based Gene Therapy Market, Historic, 2015 – 2020, $ Million

Figure 53: USA Nucleic Acid Based Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 54: USA Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 55: South America Nucleic Acid Based Gene Therapy Market, Historic, 2015 – 2020, $ Million

Figure 56: South America Nucleic Acid Based Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 57: South America Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 58: Brazil Nucleic Acid Based Gene Therapy Market, Historic, 2015 – 2020, $ Million

Figure 59: Brazil Nucleic Acid Based Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 60: Brazil Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 61: Middle East Nucleic Acid Based Gene Therapy Market, Historic, 2015 – 2020, $ Million

Figure 62: Middle East Nucleic Acid Based Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 63: Middle East Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 64: Africa Nucleic Acid Based Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 65: Africa Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 66: Global Nucleic Acid Based Gene Therapy Market, Key Competitor Estimated Market Shares, 2020, Percentage (%)

Figure 67: Moderna Inc. – Financial Performance, 2016 - 2020, $ Billion

Figure 68: Wave Life Sciences – Financial Performance, 2016 - 2020, $ Million

Figure 69: Protagonist Therapeutics – Financial Overview, 2016 – 2020, $ Million

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the hematology drugs market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the GI drugs market research report 2022 with industry size, share, segments and market growth

Central Nervous System Drugs Market 2021 - By Type (Multiple Sclerosis (MS), Anti-Psychotic, Analgesics, Anti-Parkinson Drugs, Anesthetics, Anti-Epileptics, Anti-Depressants, Other CNS Drugs), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies/ Drug Stores), By Route Of Administration (Oral, Intravenous, Intranasal/ Inhalation), By Drug Classification (Branded Drugs, Generic Drugs), By Mode Of Purchase (Over-The-Counter Drugs, Prescription-Based Drugs), And By Region, Opportunities And Strategies – Global Forecast To 2030

View Report

CAR-T Therapy Market 2021 - By Target Antigen (CD19, CD22, BCMA), By Application (Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma), And By Region, Opportunities And Strategies – Global Forecast To 2030

View Report

Digestive Enzymes Global Market Report 2024 – By Enzyme Type (Carbohydrates, Protease, Lipase, Other Enzyme Types), By Origin (Animal, Fungi, Microbial, Plant), By Application (Indigestion, Chronic Pancreatitis, Irritable Bowel Syndrome, Other Applications), By Distribution Channel (Retail Stores, Online Stores) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Oncology Biosimilars Global Market Report 2024 – By Drug Type (Monoclonal Antibody, Immunomodulators, Hematopoietic Agents, Granulocyte Colony-Stimulating Factor (G-CSF)), By Cancer Type (Breast Cancer, Colorectal Cancer, Blood Cancer, Neutropenia Cancer, Non-Small Cell Lung Cancer, Other Cancer Types), By Distribution Type (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Corticosteroids Global Market Report 2024 – By Product (Glucocorticoids, Mineralocorticoids), By Application (Skin Allergies, Rheumatology Indications, Endocrinology, Acute Respiratory Diseases, Other Applications), By End User (Hospitals, Clinics, Research Institutes, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Interferons Global Market Report 2024 – By Type (Interferon Alpha, Interferon Beta, Interferon Gamma), By Application (Hepatitis B, Hepatitis C, Melanoma, Leukemia, Multiple Sclerosis, Renal Cell Carcinoma), By Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Monoclonal Antibodies (MAs) Global Market Report 2024 – By Source (Murine, Chimeric, Humanized, Human), By Application (Anti-Cancer, Immunological, Anti-Infective Monoclonal Antibodies (MAs), Neuropharmacological, Cardiovascular And Cerebrovascular, Other Applications), By End Users (Hospitals, Private Clinics, Research Institute) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Therapeutic Proteins Global Market Report 2024 – By Product Type (Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, Follicle Stimulating Hormone), By Function (Enzymatic and Regulatory Activity, Special Targeting Activity, Vaccines, Protein Diagnostics), By Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, Other Applications) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Nucleic Acid Based Gene Therapy Market Definition

Nucleic Acid Based Gene Therapy Market Size

Nucleic Acid Based Gene Therapy Market Drivers

Nucleic Acid Based Gene Therapy Market Restraints

Nucleic Acid Based Gene Therapy Market Trends

Opportunities And Recommendations In The Nucleic Acid Based Gene Therapy Market

Nucleic Acid Based Gene Therapy Market Segmentation

Nucleic Acid Based Gene Therapy Competitive Landscape

Major Competitors Are:

Other Competitors Include:

Table Of Contents

List Of Tables

List Of Figures

The Plasma Fractionation Market Share, Market Size, And Growth Rate 2022

The Biosimilar Therapeutic Peptides Market Share, Market Size, And Growth Rate 2022

Global Anticoagulants Market 2022 – Market Opportunities And Strategies

Latest Digestive Health Supplements Market Growth Study 2022-2026 By The Business Research Company

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the hematology drugs market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the GI drugs market research report 2022 with industry size, share, segments and market growth

CAR-T Therapy Market 2021 - By Target Antigen (CD19, CD22, BCMA), By Application (Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma), And By Region, Opportunities And Strategies – Global Forecast To 2030

Frequently Asked Questions